Gale E. Smith
2006
In 2006, Gale E. Smith earned a total compensation of $489.3K as Vice President of Vaccine Development at Novavax.
Compensation breakdown
| Non-Equity Incentive Plan | $18,000 |
|---|---|
| Option Awards | $158,885 |
| Salary | $186,766 |
| Stock Awards | $121,069 |
| Other | $4,531 |
| Total | $489,251 |
Smith received $186.8K in salary, accounting for 38% of the total pay in 2006.
Smith also received $18K in non-equity incentive plan, $158.9K in option awards, $121.1K in stock awards and $4.5K in other compensation.
Rankings
In 2006, Gale E. Smith's compensation ranked 4,735th out of 7,022 executives tracked by ExecPay. In other words, Smith earned more than 32.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,735 out of 7,022 | 33rd |
Division Manufacturing | 1,600 out of 2,413 | 34th |
Major group Chemicals And Allied Products | 420 out of 673 | 38th |
Industry group Drugs | 301 out of 518 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 65 out of 112 | 42nd |
Source: SEC filing on April 30, 2007.
Smith's colleagues
We found nine more compensation records of executives who worked with Gale E. Smith at Novavax in 2006.
2006
Rahul ScD
Novavax
Chief Executive Officer
2006
Raymond Hage
Novavax
Sr. Vice President, Commercial Operations
2006
Stephen Bandak
Novavax
Former Vice President, Medical Affairs
2006
Raymond Hage
Novavax
SVP of Commercial Operations
2006
Rick Bright
Novavax
Vice President of Global Influenza Programs
2006
Dennis Genge
Novavax
Chief Financial Officer
2006
Jeffrey Church
Novavax
Chief Financial Officer
2006
Patricia Hall
Novavax
Chief Accounting Officer
2006
Penny Heaton
Novavax